Harnessing Immune Cell Metabolism to Modulate Alloresponse in Transplantation

• DOI: 10.3389/ti.2024.12330
• Publication Date: 2024-03-19T09:58:25Z
• Authors: Johan Noble; Zuzana Macek Jilkova; Caroline Aspord; Paolo Malvezzi; Miguel Fribourg; Leonardo V. Riella; Paolo Cravedi
• Keywords: 0301 basic medicine; Specialties of internal medicine; Cell Differentiation; glycolysis; Adaptive Immunity; Health Archive; T-Lymphocytes, Regulatory; 03 medical and health sciences; immune cells; RC581-951; Humans; rejection; solid organ transplantation; metabolism; Glycolysis

Immune cell metabolism plays a pivotal role in shaping and modulating immune responses. The metabolic state of immune cells influences their development, activation, differentiation, and overall function, impacting both innate and adaptive immunity. While glycolysis is crucial for activation and effector function of CD8 T cells, regulatory T cells mainly use oxidative phosphorylation and fatty acid oxidation, highlighting how different metabolic programs shape immune cells. Modification of cell metabolism may provide new therapeutic approaches to prevent rejection and avoid immunosuppressive toxicities. In particular, the distinct metabolic patterns of effector and suppressive cell subsets offer promising opportunities to target metabolic pathways that influence immune responses and graft outcomes. Herein, we review the main metabolic pathways used by immune cells, the techniques available to assay immune metabolism, and evidence supporting the possibility of shifting the immune response towards a tolerogenic profile by modifying energetic metabolism.